Skip to main content
. 2021 Jan 25;11:613883. doi: 10.3389/fphar.2020.613883

FIGURE 3.

FIGURE 3

Protective effect of activated STAT3 in the viral myocarditis (A) The related proteins were measured by western blot (n = 4). **p < 0.01 vs control groups (NC and AG490 group), p < 0.05 vs CVB3 groups (CVB3 and AG490 + CVB3 group) (B) HE staining of myocardium (n = 4,200×) and cardiac pathological scores (n = 4) **p < 0.01vs control groups (NC and AG490 group), p < 0.05 vs CVB3 groups (CVB3 and AG490 + CVB3 group) (C) M-mode echocardiogram images and analysis of LVEF and LVFS in different groups (n = 3). **p < 0.01vs control groups (NC and AG490 group), p < 0.05 vs CVB3 groups (CVB3 and AG490 + CVB3 group) (D) Survival analysis of viral myocarditis mice. Survival proportions at day 7 were 100% for the NC group and AG490 group, 52% for the CVB3 group, 36% for the CVB3+AG490 group. **p < 0.01 vs control groups (NC and AG490 group), p < 0.05 vs CVB3 groups (CVB3 and AG490 + CVB3 group).